If a senior loses weight but also loses significant muscle mass, is the treatment really a success?” GLP-1s are meant for ...

A common diabetes drug may hold great potential to help with aging, even if scientists aren't exactly sure why. According to a study, the drug metformin doesn't just help patients to effectively ...

Medicines called glucagon-like peptide-1 (GLP-1) receptor agonists have changed how type 2 diabetes is treated. GLP-1 medicines, like semaglutide (Rybelsus), work by acting like the body’s natural GLP ...

Ozempic carries a boxed warning regarding the risk of thyroid cancer. A boxed warning is the most serious warning from the Food and Drug Administration (FDA). There’s no direct interaction between ...

New real-world evidence suggests that staying on GLP-1 therapy may be critical for sustaining cardiovascular protection, while even short interruptions could diminish long-term benefits in people with ...

Moderate-risk patients with diabetes treated with a sulfonylurea appear to be at a higher risk of major adverse cardiovascular events than those who receive a dipeptidyl peptidase-4 (DPP-4) inhibitor, ...

A comparative effectiveness research study compared MACE rates among initiators of sulfonylureas versus DPP4 inhibitors for T2D. Glipizide in particular showed a significant link to cardiovascular ...

1. There is limited evidence that glyburide (a sulfonylurea, or type of medicine used for type 2 diabetes) may have little to no effect on a person's function 90 days after a stroke, or the number of ...

Discover comprehensive details about Chlorpropamide, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated ...

Odds are lessened with regular diabetes-related medical care. (HealthDay News) — The prevalence of impaired awareness of hypoglycemia (IAH) is high among patients using sulfonylureas long term, ...